CN1899535A - Method for preparing dermopathic blood toxic capsule - Google Patents

Method for preparing dermopathic blood toxic capsule Download PDF

Info

Publication number
CN1899535A
CN1899535A CNA2006100363301A CN200610036330A CN1899535A CN 1899535 A CN1899535 A CN 1899535A CN A2006100363301 A CNA2006100363301 A CN A2006100363301A CN 200610036330 A CN200610036330 A CN 200610036330A CN 1899535 A CN1899535 A CN 1899535A
Authority
CN
China
Prior art keywords
radix
capsule
raw material
preparation
dermopathic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CNA2006100363301A
Other languages
Chinese (zh)
Inventor
柯树泉
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
PIBAO PHARMACEUTICAL CO Ltd GUANGDONG
Original Assignee
PIBAO PHARMACEUTICAL CO Ltd GUANGDONG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by PIBAO PHARMACEUTICAL CO Ltd GUANGDONG filed Critical PIBAO PHARMACEUTICAL CO Ltd GUANGDONG
Priority to CNA2006100363301A priority Critical patent/CN1899535A/en
Publication of CN1899535A publication Critical patent/CN1899535A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)

Abstract

The dermopathic blood poison treating capsule for treating dermopathy is prepared with madder and other 38 kinds of Chinese medicinal materials, and through washing, drying, crushing, grinding into fine powder, mixing with proper amount of talc powder and encapsulating. It can cleare away blood heat and toxic matter, eliminating swelling and stopping itching. Grinding the materials into fine powder of size below 47 micron can speed the absorption of skin on the effective medicine components and raise the healing effect greatly.

Description

A kind of preparation method of dermopathic blood toxic capsule
Technical field
The present invention relates to a kind of endo-medicine for the treatment of dermatosis, particularly relate to a kind of being used for the treatment of because of meridians discord, the dry preparation method that causes the dermopathic blood toxic capsule of dermatosis of damp and hot blood.
Background technology
Human body causes dermatosis such as rubella, eczema, scratchy, freckle as well as acne, face thorn brandy nose, sore swollen toxin, beriberi scabies easily because of meridians discord, damp and hot blood are dry." the dermopathic blood poison pill " of Xiao Shouing is though also have the effect of blood-cleaning detoxifying, repellent antipruritic on the market, but because the preparation method of this product is to continue to use the production technology of traditional water pill dosage form, whole pulverizing medicinal materials in only will filling a prescription are to the 80-100 order, water is adhesion-molded, therefore this product exists obviously not enough: (1) is unfavorable for that the active ingredient in the medical material oozes out from plant cell, active ingredient in the medical material is absorbed not exclusively, cause waste; (2) dosage that need take is big, is unfavorable for that the people swallows; (3) the product onset is slow, can not bring into play curative effect the fastest, the biglyyest; (4) the easy moisture absorption of water pill dosage form causes that product is mouldy, preserves and carry all inconvenient.
Summary of the invention
At above problem, the invention provides a kind of preparation method of dermopathic blood toxic capsule, promptly adopt superfine communication technique, prepare novel dermopathic blood toxic capsule.Concrete technical scheme is as follows:
A kind of preparation method of dermopathic blood toxic capsule is equipped with raw material by following proportioning earlier: Radix Rubiae 30g, Semen Persicae 30g, Herba Schizonepetae 30g, Periostracum Serpentis 15g, Radix Paeoniae Rubra 30g, Radix Angelicae Sinensis 30g, Rhizoma Imperatae 60g, Fructus Kochiae 30g, Fructus Xanthii 30g, Radix Rehmanniae 30g, Fructus Forsythiae 30g, Flos Lonicerae 30g, Herba Corydalis Bungeanae 30g, Rhizoma Smilacis Glabrae 30g, Cortex Phellodendri 15g, Spina Gleditsiae 30g, Radix Platycodonis 30g, Herba Leonuri 30g, Semen Armeniacae Amarum 30g, Radix Saposhnikoviae 15g, red volt Siberian cocklebur 60g, Radix Paeoniae Alba 30g, Periostracum Cicadae 15g, Fructus Arctii 30g, Cortex Moutan 30g, Cortex Dictamni 30g, Radix Rehmanniae Preparata 30g, Radix Et Rhizoma Rhei 30g, Caulis Lonicerae 30g, Radix Arnebiae (Radix Lithospermi) 15g, Rhizoma Bolbostematis 30g, Rhizoma Chuanxiong 15g, Radix Glycyrrhizae 30g, Radix Angelicae Dahuricae 15g, Radix Semiaquilegiae 30g, Cortex cercis chinensis 15g, Caulis Spatholobi 30g, Herba Spirodelae 15g, Flos Carthami 15g; Be prepared according to the following steps then:
1) above-mentioned raw materials is cleaned up;
2) clean raw material is carried out drying;
3) dried raw material is ground into coarse powder, crosses the 80-100 mesh sieve;
4) above-mentioned coarse powder is carried out micronizing again, cross 300 mesh sieves, get micropowders;
5) add an amount of Pulvis Talci in above-mentioned micropowders, mix homogeneously is inserted in the capsule then, can obtain required finished product.
In the above-mentioned preparation method, the temperature of raw material drying is 60-100 ℃, and the exsiccant time is 4-6 hour.
In the above-mentioned preparation method, adding talcous amount is 1% of micropowders total amount.
In the above-mentioned preparation method, the capsule that product is selected for use is a medicinal hard capsule, and model is No. 0 or No. 00.
In the above-mentioned preparation method, the micronizing of raw material is to carry out being lower than under 10 ℃ the temperature, to avoid the destruction of the high temperature gelatinizing of medical material in crushing process to active ingredient.
In the above-mentioned preparation method, the micronizing of raw material realizes by jet mill, vibromill, ball mill or planetary mills.
The said flow pulverizer comprises horizontal circle disc type jet mill, circulation tubular type jet mill, to spray formula inverted draft pulverizer, crash panel target formula jet mill or fluidized bed type jet mill.
Product-dermopathic blood toxic capsule of the present invention is formed its function blood-cleaning detoxifying, repellent antipruritic by 39 flavor Chinese medicines such as Radix Rubiae, Radix Paeoniae Rubra, the Fructus Kochiae, Cortex Moutan, Radix Et Rhizoma Rhei (wine stir-fry), Rhizoma Smilacis Glabrae, Flos Lonicerae, red volt Siberian cocklebur, Cortex Dictamni, Rhizoma Imperatae, Herba Corydalis Bungeanae, Spina Gleditsiae.The clinical dermatosis such as meridians discord, the dry rubella that causes of damp and hot blood, eczema, scratchy, freckle as well as acne, face thorn brandy nose, sore swollen toxin, beriberi scabies that are used for the treatment of, determined curative effect is a kind of outstanding dermatosis oral medicine.
It is broken that the present invention carries out micropowder to 39 flavor medical materials, and promptly the cell grade micropowder is broken, and diameter of particle reaches (fully by 300 mesh sieves) below 47 microns.The cell grade micropowder is broken to be to break the disintegrating process technology that the Chinese crude drug cell is a purpose, cell wall in the crushing process (film) is broken, to more help alleviating it active ingredient will be discharged formed resistance, and cellular content is directly exposed and improve its dissolution, thereby make human body tangible breakthrough arranged to the assimilation ratio and the speed of effective ingredient, thereby the single that makes the patient takes quantity and significantly reduces, and also improved the treating for skin disease effect.In addition, product of the present invention is made capsule, more helps preserving and carrying.
The specific embodiment
Embodiment 1
Get Radix Rubiae 30g, Semen Persicae 30g, Herba Schizonepetae 30g, Periostracum Serpentis 15g, Radix Paeoniae Rubra 30g, Radix Angelicae Sinensis 30g, Rhizoma Imperatae 60g, Fructus Kochiae 30g, Fructus Xanthii 30g, Radix Rehmanniae 30g, Fructus Forsythiae 30g, Flos Lonicerae 30g, Herba Corydalis Bungeanae 30g, Rhizoma Smilacis Glabrae 30g, Cortex Phellodendri 15g, Spina Gleditsiae 30g, Radix Platycodonis 30g, Herba Leonuri 30g, Semen Armeniacae Amarum 30g, Radix Saposhnikoviae 15g, red volt Siberian cocklebur 60g, Radix Paeoniae Alba 30g, Periostracum Cicadae 15g, Fructus Arctii 30g, Cortex Moutan 30g, Cortex Dictamni 30g, Radix Rehmanniae Preparata 30g, Radix Et Rhizoma Rhei 30g, Caulis Lonicerae 30g, Radix Arnebiae (Radix Lithospermi) 15g, Rhizoma Bolbostematis 30g, Rhizoma Chuanxiong 15g, Radix Glycyrrhizae 30g, Radix Angelicae Dahuricae 15g, Radix Semiaquilegiae 30g, Cortex cercis chinensis 15g, Caulis Spatholobi 30g, Herba Spirodelae 15g, Flos Carthami 15g; Be prepared according to the following steps then:
1) above-mentioned raw materials is cleaned up;
2) clean raw material is carried out drying, exsiccant temperature is 60 ℃, and the time is 6 hours;
3) dried raw material is ground into coarse powder, crosses 80 mesh sieves;
4) above-mentioned coarse powder is carried out micronizing again, cross 300 mesh sieves, get micropowders;
5) add Pulvis Talci in above-mentioned micropowders, talcous amount is 1% of a micropowders total amount, and mix homogeneously is then inserted in No. 0 capsule, can obtain required dermopathic blood toxic capsule.
Be equipped with raw material in above ratio during batch process.
Embodiment 2
Get Radix Rubiae 30g, Semen Persicae 30g, Herba Schizonepetae 30g, Periostracum Serpentis 15g, Radix Paeoniae Rubra 30g, Radix Angelicae Sinensis 30g, Rhizoma Imperatae 60g, Fructus Kochiae 30g, Fructus Xanthii 30g, Radix Rehmanniae 30g, Fructus Forsythiae 30g, Flos Lonicerae 30g, Herba Corydalis Bungeanae 30g, Rhizoma Smilacis Glabrae 30g, Cortex Phellodendri 15g, Spina Gleditsiae 30g, Radix Platycodonis 30g, Herba Leonuri 30g, Semen Armeniacae Amarum 30g, Radix Saposhnikoviae 15g, red volt Siberian cocklebur 60g, Radix Paeoniae Alba 30g, Periostracum Cicadae 15g, Fructus Arctii 30g, Cortex Moutan 30g, Cortex Dictamni 30g, Radix Rehmanniae Preparata 30g, Radix Et Rhizoma Rhei 30g, Caulis Lonicerae 30g, Radix Arnebiae (Radix Lithospermi) 15g, Rhizoma Bolbostematis 30g, Rhizoma Chuanxiong 15g, Radix Glycyrrhizae 30g, Radix Angelicae Dahuricae 15g, Radix Semiaquilegiae 30g, Cortex cercis chinensis 15g, Caulis Spatholobi 30g, Herba Spirodelae 15g, Flos Carthami 15g; Be prepared according to the following steps then:
1) above-mentioned raw materials is cleaned up;
2) clean raw material is carried out drying, exsiccant temperature is 80 ℃, and the time is 5 hours;
3) dried raw material is ground into coarse powder, crosses 100 mesh sieves;
4) above-mentioned coarse powder is carried out micronizing again, cross 300 mesh sieves, get micropowders;
5) add Pulvis Talci in above-mentioned micropowders, talcous amount is 1% of a micropowders total amount, and mix homogeneously is then inserted in No. 00 capsule, can obtain required dermopathic blood toxic capsule.
Be equipped with raw material in above ratio during batch process.
Embodiment 3
Get Radix Rubiae 30g, Semen Persicae 30g, Herba Schizonepetae 30g, Periostracum Serpentis 15g, Radix Paeoniae Rubra 30g, Radix Angelicae Sinensis 30g, Rhizoma Imperatae 60g, Fructus Kochiae 30g, Fructus Xanthii 30g, Radix Rehmanniae 30g, Fructus Forsythiae 30g, Flos Lonicerae 30g, Herba Corydalis Bungeanae 30g, Rhizoma Smilacis Glabrae 30g, Cortex Phellodendri 15g, Spina Gleditsiae 30g, Radix Platycodonis 30g, Herba Leonuri 30g, Semen Armeniacae Amarum 30g, Radix Saposhnikoviae 15g, red volt Siberian cocklebur 60g, Radix Paeoniae Alba 30g, Periostracum Cicadae 15g, Fructus Arctii 30g, Cortex Moutan 30g, Cortex Dictamni 30g, Radix Rehmanniae Preparata 30g, Radix Et Rhizoma Rhei 30g, Caulis Lonicerae 30g, Radix Arnebiae (Radix Lithospermi) 15g, Rhizoma Bolbostematis 30g, Rhizoma Chuanxiong 15g, Radix Glycyrrhizae 30g, Radix Angelicae Dahuricae 15g, Radix Semiaquilegiae 30g, Cortex cercis chinensis 15g, Caulis Spatholobi 30g, Herba Spirodelae 15g, Flos Carthami 15g; Be prepared according to the following steps then:
1) above-mentioned raw materials is cleaned up;
2) clean raw material is carried out drying, exsiccant temperature is 100 ℃, and the time is 4 hours;
3) dried raw material is ground into coarse powder, crosses 80 mesh sieves;
4) above-mentioned coarse powder is carried out micronizing again, cross 300 mesh sieves, get micropowders;
5) add Pulvis Talci in above-mentioned micropowders, talcous amount is 1% of a micropowders total amount, and mix homogeneously is then inserted in No. 00 capsule, can obtain required dermopathic blood toxic capsule.
Be equipped with raw material in above ratio during batch process.
Among the above embodiment, can utilize jet mill, vibromill, ball mill or planetary mills to realize to the micronizing of raw material, wherein jet mill can be horizontal circle disc type jet mill, circulation tubular type jet mill, to spray formula inverted draft pulverizer, crash panel target formula jet mill, fluidized bed type jet mill.The broken operation of micropowder is generally carried out being lower than under 10 ℃.
The dermopathic blood toxic capsule that the present invention is prepared, through medical institutions' clinical verifications such as Guangzhou Affiliated Hospital of Zhongshan Medical Univ., Guangzhou No.2 People's Hospital, product has the effect of blood-cleaning detoxifying, repellent antipruritic, treatment is stung dermatosis such as brandy nose, sore swollen toxin, beriberi scabies, determined curative effect because of meridians discord, the dry rubella that causes of damp and hot blood, eczema, scratchy, freckle as well as acne, face.

Claims (7)

1. the preparation method of a dermopathic blood toxic capsule is characterized in that: be equipped with raw material by following proportioning earlier: Radix Rubiae 30g, Semen Persicae 30g, Herba Schizonepetae 30g, Periostracum Serpentis 15g, Radix Paeoniae Rubra 30g, Radix Angelicae Sinensis 30g, Rhizoma Imperatae 60g, Fructus Kochiae 30g, Fructus Xanthii 30g, Radix Rehmanniae 30g, Fructus Forsythiae 30g, Flos Lonicerae 30g, Herba Corydalis Bungeanae 30g, Rhizoma Smilacis Glabrae 30g, Cortex Phellodendri 15g, Spina Gleditsiae 30g, Radix Platycodonis 30g, Herba Leonuri 30g, Semen Armeniacae Amarum 30g, Radix Saposhnikoviae 15g, red volt Siberian cocklebur 60g, Radix Paeoniae Alba 30g, Periostracum Cicadae 15g, Fructus Arctii 30g, Cortex Moutan 30g, Cortex Dictamni 30g, Radix Rehmanniae Preparata 30g, Radix Et Rhizoma Rhei 30g, Caulis Lonicerae 30g, Radix Arnebiae (Radix Lithospermi) 15g, Rhizoma Bolbostematis 30g, Rhizoma Chuanxiong 15g, Radix Glycyrrhizae 30g, Radix Angelicae Dahuricae 15g, Radix Semiaquilegiae 30g, Cortex cercis chinensis 15g, Caulis Spatholobi 30g, Herba Spirodelae 15g, Flos Carthami 15g; Be prepared according to the following steps then:
1) above-mentioned raw materials is cleaned up;
2) clean raw material is carried out drying;
3) dried raw material is ground into coarse powder, crosses the 80-100 mesh sieve;
4) above-mentioned coarse powder is carried out micronizing again, cross 300 mesh sieves, get micropowders;
5) add an amount of Pulvis Talci in above-mentioned micropowders, mix homogeneously is inserted in the capsule then, can obtain required finished product.
2. the preparation method of dermopathic blood toxic capsule according to claim 1, it is characterized in that: the temperature of raw material drying is 60-100 ℃, the exsiccant time is 4-6 hour.
3. the preparation method of dermopathic blood toxic capsule according to claim 1, it is characterized in that: adding talcous amount is 1% of micropowders total amount.
4. the preparation method of dermopathic blood toxic capsule according to claim 1, it is characterized in that: the capsule that product is selected for use is a medicinal hard capsule, model is No. 0 or No. 00.
5, according to the preparation method of each described dermopathic blood toxic capsule of claim 1-4, it is characterized in that: the micronizing of raw material is to carry out being lower than under 10 ℃ the temperature.
6, according to the preparation method of each described dermopathic blood toxic capsule of claim 1-4, it is characterized in that: the micronizing of raw material realizes by jet mill, vibromill, ball mill or planetary mills.
7, the preparation method of dermopathic blood toxic capsule according to claim 6 is characterized in that: described jet mill comprises horizontal circle disc type jet mill, circulation tubular type jet mill, to spray formula inverted draft pulverizer, crash panel target formula jet mill, fluidized bed type jet mill.
CNA2006100363301A 2006-06-28 2006-06-28 Method for preparing dermopathic blood toxic capsule Pending CN1899535A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CNA2006100363301A CN1899535A (en) 2006-06-28 2006-06-28 Method for preparing dermopathic blood toxic capsule

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CNA2006100363301A CN1899535A (en) 2006-06-28 2006-06-28 Method for preparing dermopathic blood toxic capsule

Publications (1)

Publication Number Publication Date
CN1899535A true CN1899535A (en) 2007-01-24

Family

ID=37655646

Family Applications (1)

Application Number Title Priority Date Filing Date
CNA2006100363301A Pending CN1899535A (en) 2006-06-28 2006-06-28 Method for preparing dermopathic blood toxic capsule

Country Status (1)

Country Link
CN (1) CN1899535A (en)

Cited By (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102068639A (en) * 2011-01-10 2011-05-25 王宝香 Externally traditional Chinese medicine for treating pustulosis
CN101642546B (en) * 2009-06-14 2011-05-25 李承平 Chinese patent medicine for eliminating toxin and beautifying faces
CN101596270B (en) * 2009-07-01 2011-06-29 李春荣 Medicine for treating chronic pharyngitis and preparation method thereof
CN102178874A (en) * 2010-12-14 2011-09-14 史志辉 Preparation method of Chinese medicinal tablet for treating skin diseases
CN102274322A (en) * 2011-08-04 2011-12-14 长春市南关区中医院 Chinese medicinal preparation for treating eczema
CN102379968A (en) * 2011-10-18 2012-03-21 孙克勤 Traditional Chinese medicine composition for treating purpura
CN102973836A (en) * 2012-12-28 2013-03-20 李鑫 Traditional Chinese medicine formula for curing pediatric chronic urticaria
CN103356777A (en) * 2013-07-17 2013-10-23 张桂凤 Medicament for treating rosacea
CN103550680A (en) * 2013-10-22 2014-02-05 张礼周 Traditional Chinese medicine prescription for treating hyperbilirubinemia caused skin itch and preparation method thereof
CN104547718A (en) * 2015-01-30 2015-04-29 张希梅 Pharmaceutical composition for preventing and treating children fracture internal fixation postoperative infection
CN104667070A (en) * 2015-02-12 2015-06-03 广东国医堂制药股份有限公司 Medicine for treating skin diseases and preparation method of medicine
CN105232684A (en) * 2015-11-18 2016-01-13 包莉丽 Medicine for treating chronic eczema
CN108514551A (en) * 2018-05-18 2018-09-11 北京同仁堂制药有限公司 A kind of preparation method of medicine pill

Cited By (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101642546B (en) * 2009-06-14 2011-05-25 李承平 Chinese patent medicine for eliminating toxin and beautifying faces
CN101596270B (en) * 2009-07-01 2011-06-29 李春荣 Medicine for treating chronic pharyngitis and preparation method thereof
CN102178874B (en) * 2010-12-14 2012-02-29 史志辉 Preparation method of Chinese medicinal tablet for treating skin diseases
CN102178874A (en) * 2010-12-14 2011-09-14 史志辉 Preparation method of Chinese medicinal tablet for treating skin diseases
CN102068639A (en) * 2011-01-10 2011-05-25 王宝香 Externally traditional Chinese medicine for treating pustulosis
CN102274322B (en) * 2011-08-04 2013-03-27 长春市南关区中医院 Chinese medicinal preparation for treating eczema
CN102274322A (en) * 2011-08-04 2011-12-14 长春市南关区中医院 Chinese medicinal preparation for treating eczema
CN102379968B (en) * 2011-10-18 2013-09-11 孙克勤 Traditional Chinese medicine composition for treating purpura
CN102379968A (en) * 2011-10-18 2012-03-21 孙克勤 Traditional Chinese medicine composition for treating purpura
CN102973836B (en) * 2012-12-28 2014-10-08 潍坊市市直机关医院 Traditional Chinese medicine formula for curing pediatric chronic urticaria
CN102973836A (en) * 2012-12-28 2013-03-20 李鑫 Traditional Chinese medicine formula for curing pediatric chronic urticaria
CN103356777A (en) * 2013-07-17 2013-10-23 张桂凤 Medicament for treating rosacea
CN103356777B (en) * 2013-07-17 2015-02-18 张桂凤 Medicament for treating rosacea
CN103550680A (en) * 2013-10-22 2014-02-05 张礼周 Traditional Chinese medicine prescription for treating hyperbilirubinemia caused skin itch and preparation method thereof
CN103550680B (en) * 2013-10-22 2015-12-30 张礼周 A kind ofly treat hyperbilirubinemia Chinese medicinal formulae causing skin pruritus and preparation method thereof
CN104547718A (en) * 2015-01-30 2015-04-29 张希梅 Pharmaceutical composition for preventing and treating children fracture internal fixation postoperative infection
CN104667070A (en) * 2015-02-12 2015-06-03 广东国医堂制药股份有限公司 Medicine for treating skin diseases and preparation method of medicine
CN105232684A (en) * 2015-11-18 2016-01-13 包莉丽 Medicine for treating chronic eczema
CN108514551A (en) * 2018-05-18 2018-09-11 北京同仁堂制药有限公司 A kind of preparation method of medicine pill

Similar Documents

Publication Publication Date Title
CN1899535A (en) Method for preparing dermopathic blood toxic capsule
CN101987123B (en) Medicament for easing pain of human body and preparation method thereof
CN101987122B (en) Medicament for easing pain of human body and preparation method thereof
CN101632737A (en) Medicament for relieving pain of human body and preparation method thereof
CN101366858B (en) Preparation method of medicament for clearing heat, discharging fire, dispelling wind and relieving pain
CN1943727A (en) A Chinese traditional medicinal composition for treatment of psoriasis
CN1166388C (en) Medicine for treating nosal inflammation
CN1927279A (en) Chinese medicine composition for treating skin disease
CN1742904A (en) Chinese medicine for treating urinary stone and urinary system inflammation, and production method thereof
CN1151823C (en) Medicine for preventing and treating cold and its preparing process
CN1600356A (en) Combination of Chinese traditional medicine for curing chronic pharyngitis and preparation method
CN1041601C (en) Traditional Chinese medicine for treating migraine
CN1899482A (en) Medicine for treating chronic glomerular nephritis and its producing method
CN100352487C (en) Pure Chinese medicine for treating chronic rhinitis, pharyngitis and globus hysterics
CN1899574A (en) Chinese medicine composition for preventing and controlling liver cancer and its use
CN1261130C (en) Medicine for dispelling tinea
CN1186056C (en) Medicine for treating osteoproliferation
CN1899439A (en) Chinese medicine composition for treating goat and its use
CN1111045C (en) Chewing medicine for treating facial paralysis and its preparing process
CN1768803A (en) Medicine for treating hypertension and its preparing process
CN1103796A (en) Dressing medicine for treating hyperosteogeny and the prepn. method
CN1060663C (en) Compound Tibet capillary artemisia patent medicine
CN1579513A (en) Compound throat sucking-tablet of semen sterculiae scaphigerae and oral tonic thereof
CN1704084A (en) Chinese medicinal preparation for treating schizophrenia, its preparation and application method
CN108553584B (en) Composition for assisting in reducing blood sugar and application thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C12 Rejection of a patent application after its publication
RJ01 Rejection of invention patent application after publication